Effects of prior bevacizumab (B) use on outcomes from the VELOUR study: A phase III study of aflibercept (Afl) and FOLFIRI in patients (pts) with metastatic colorectal cancer (mCRC) after failure of an oxaliplatin regimen - Allegra, C J; Lakomy, R; Tabernero, J (J Clin Oncol, 2012)
(suppl; abstr 3505)